Paper: Data Science and AI in drug development– challenges and case studies from AstraZeneca
Anders Broo has a PhD in theoretical and physical chemistry from University of Gothenburg, Sweden (1991). After post-doc’s in Uppsala and Florida he returned to Sweden for an assistant and associate professor position at Chalmers Technical University, Gothenburg, Sweden. Anders has published 48 peer reviewed articles and is co-inventor on 3 patents. The research filed spans from electron transfer, photochemistry of DNA bases, medicinal chemistry, chemical stability and materials chemistry. Since joining AstraZeneca 2001 Anders has lead line organizations in discovery and development and lead drug discovery projects and business change programs. In his current role as head of department he leads the digital transformation of the Pharmaceutical Sciences research unit